Inventor · disambiguated record
Vanessa Taylor
Also filed as: TAYLOR VANESSA · TAYLOR VANESSA CLAIRE
89 granted patents·23 pending applications·637 citations·filing 2005–2024
99Inventor score
Top patents by PatentIndex Score
112 records- 0198US11479543B2Heterocyclic RIP1 kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Oct 25, 2022·5 cites·3 claims
- 0297US11407736B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·4 cites·8 claims
- 0397US10975064B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Apr 13, 2021·14 cites·18 claims
- 0497US7858633B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Dec 28, 2010·66 cites·5 claims
- 0597US7834024B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Nov 16, 2010·59 cites·6 claims
- 0696US11584758B2RIP1K inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Feb 21, 2023·5 cites·37 claims
- 0796US11332451B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted May 17, 2022·3 cites·13 claims
- 0896US10815206B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·16 cites·17 claims
- 0996US10590121B2Kinase inhibitors and methods for making and usingRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·10 cites·37 claims
- 1096US8415365B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2008·Granted Apr 9, 2013·31 cites·20 claims
- 1196US7947698B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted May 24, 2011·55 cites·54 claims
- 1296US7915273B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Mar 29, 2011·33 cites·2 claims
- 1396US7754714B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·39 cites·24 claims
- 1495US9982000B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·16 cites·14 claims
- 1595US8735400B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted May 27, 2014·21 cites·24 claims
- 1695US8399472B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2008·Granted Mar 19, 2013·26 cites·4 claims
- 1795US8324200B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Dec 4, 2012·23 cites·46 claims
- 1894US11370787B2Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulationsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·4 cites·23 claims
- 1994US7868013B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jan 11, 2011·25 cites·12 claims
- 2093US11377428B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jul 5, 2022·2 cites·13 claims
- 2193US11370765B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·2 cites·13 claims
- 2293US11370764B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·2 cites·13 claims
- 2393US8299087B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Oct 30, 2012·11 cites·4 claims
- 2492US9067925B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2012·Granted Jun 30, 2015·11 cites·10 claims
- 2591US11198689B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Dec 14, 2021·2 cites·18 claims
- 2690US10774076B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Sep 15, 2020·3 cites·21 claims
- 2790US10208074B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·5 cites·11 claims
- 2890US8304422B2Compositions and methods for inhibition of the JAK pathwayATUEGBU ANDY·Filed 2010·Granted Nov 6, 2012·26 cites·22 claims
- 2989US10208075B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·4 cites·17 claims
- 3089US8815848B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 26, 2014·8 cites·5 claims
- 3189US8410093B2Cycloalkyl substituted pyrimidinediamine compounds and their usesLI HUI·Filed 2010·Granted Apr 2, 2013·9 cites·20 claims
- 3289US8343954B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2011·Granted Jan 1, 2013·8 cites·7 claims
- 3389US2025034100A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3489US2025326778A1Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3588US11919890B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Mar 5, 2024·1 cites·18 claims
- 3688US11530194B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Dec 20, 2022·1 cites·24 claims
- 3788US11492349B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Nov 8, 2022·1 cites·21 claims
- 3888US9732073B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·4 cites·17 claims
- 3988US9611260B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Apr 4, 2017·4 cites·14 claims
- 4087US10421752B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Sep 24, 2019·3 cites·14 claims
- 4187US9725419B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 8, 2017·7 cites·3 claims
- 4287US9566283B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·3 cites·12 claims
- 4387US9248132B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·4 cites·1 claims
- 4487US9084795B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·4 cites·19 claims
- 4587US2024368119A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4686US11299486B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·1 cites·11 claims
- 4786US10065946B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Sep 4, 2018·4 cites·24 claims
- 4886US8268851B2Compositions and methods for inhibition of the JAK pathwayBHAMIDIPATI SOMASEKHAR·Filed 2009·Granted Sep 18, 2012·8 cites·14 claims
- 4985US9481654B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Nov 1, 2016·5 cites·19 claims
- 5085US9248190B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·4 cites·7 claims
Showing the top 50 of 112 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Vanessa Taylor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →